Compare CALM & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CALM | ZLAB |
|---|---|---|
| Founded | 1957 | 2013 |
| Country | United States | China |
| Employees | 4909 | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.6B |
| IPO Year | 1996 | 2017 |
| Metric | CALM | ZLAB |
|---|---|---|
| Price | $67.19 | $25.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $92.00 | $49.60 |
| AVG Volume (30 Days) | ★ 819.5K | 755.7K |
| Earning Date | 04-01-2026 | 05-07-2026 |
| Dividend Yield | ★ 11.13% | N/A |
| EPS Growth | N/A | ★ 38.46 |
| EPS | ★ 6.63 | N/A |
| Revenue | ★ $2,911,632,000.00 | $460,156,000.00 |
| Revenue This Year | N/A | $9.75 |
| Revenue Next Year | N/A | $26.03 |
| P/E Ratio | $10.17 | ★ N/A |
| Revenue Growth | N/A | ★ 15.33 |
| 52 Week Low | $66.62 | $15.96 |
| 52 Week High | $96.59 | $34.72 |
| Indicator | CALM | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 21.28 | 58.53 |
| Support Level | N/A | $17.51 |
| Resistance Level | $80.00 | $27.20 |
| Average True Range (ATR) | 1.90 | 0.80 |
| MACD | -0.48 | -0.08 |
| Stochastic Oscillator | 7.98 | 80.71 |
Cal-Maine Foods Inc is an egg company in the U.S. Its shell egg portfolio includes conventional, specialty, cage-free, nutritionally enhanced, organic, brown, pasture-raised, and free-range eggs. The Company operates through the Conventional Shell Eggs, Specialty Shell Eggs and Prepared Foods segments, with Conventional Shell Eggs generating maximum revenue. The Conventional Shell Eggs segment consists mainly of the production, grading, packaging, marketing and distribution of conventional shell eggs, including Sunups and Sunny Meadow. The Company sells its products to grocery store chains, club stores, independent supermarkets, and foodservice distributors serving restaurants, convenience stores, healthcare and education facilities, and hotels throughout the U.S.
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.